Nature and Magnitude of the Benefits of Dapagliflozin and Empagliflozin for Heart Failure

Circulation. 2024 Mar 12;149(11):839-842. doi: 10.1161/CIRCULATIONAHA.123.068089. Epub 2024 Mar 11.
No abstract available

Keywords: Editorials; heart failure; prognosis; quality of life; sodium-glucose transporter 2 inhibitors; symptoms; trials.

Publication types

  • Editorial
  • Comment

MeSH terms

  • Benzhydryl Compounds* / therapeutic use
  • Glucosides*
  • Heart Failure* / drug therapy
  • Humans
  • Randomized Controlled Trials as Topic

Substances

  • empagliflozin
  • dapagliflozin
  • Benzhydryl Compounds
  • Glucosides